GlassScriptPhysician profile
Chad L Thompson
NPI 1952367914
$3,628.81
in general payments reported to CMS, 2019-2025
43 companies · $716 in 2025
The $716 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $367 · 2021: $351 · 2022: $452 · 2023: $1,159 · 2024: $366 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,491 · Consulting Fee: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,491.16 |
| Consulting Fee | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $967.75 | 2020-2025 | Licart, Tirosint, Licart |
| Stryker Corporation | $312.19 | 2021-2025 | Ortholoc 3di Crosscheck, Ortholoc 2 Lapifuse, Anchorage |
| Smith+Nephew, INC. | $240.35 | 2020-2024 | Collagenase Santyl, Grafix, Acticoat 4" X 4" |
| Pacira Pharmaceuticals Incorporated | $196.79 | 2024-2025 | Exparel |
| Restor3d, INC. | $176.58 | 2025 | |
| Melinta Therapeutics, LLC | $154.16 | 2019-2020 | |
| Impactortho, INC. | $117.51 | 2021-2025 | |
| Kerecis Limited | $116.42 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Orthofix Medical, INC. | $102.34 | 2019-2025 | Physio-Stim, Accelstim |
| Organogenesis INC. | $93.16 | 2020-2025 | Puraply, Via Matrix |
| Aap Implants INC | $91.36 | 2022 | |
| Bioventus LLC | $82.51 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Paratek Pharmaceuticals, INC. | $75.17 | 2022-2025 | Nuzyra |
| Horizon Therapeutics Plc | $67.72 | 2020-2023 | Krystexxa |
| Fusion Orthopedics USA, LLC | $67.02 | 2024-2025 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.